Fig. 7From: Scope and relevance of a pulmonary biopharmaceutical classification system AAPS/FDA/USP Workshop March 16-17th, 2015 in Baltimore, MDA summary of the lung doses achieved with the major inhalation delivery technologies and drug classes as determined by gamma scintigraphy. (From (Clark 2015))Back to article page